Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.

@article{Almras2011MonthlySF,
  title={Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients.},
  author={Cyrielle Alm{\'e}ras and Fernando Vetromile and Val{\'e}rie Garrigue and Ilan Szwarc and Vincent Foulongne and Georges Mourad},
  journal={Transplant infectious disease : an official journal of the Transplantation Society},
  year={2011},
  volume={13 2},
  pages={101-8}
}
BACKGROUND BK polyomavirus virus (BKV) nephropathy (BKVN) is the most common viral infection that affects renal allografts. Because a specific antiviral therapy is lacking, BKVN may result in graft dysfunction and/or loss. We prospectively analyzed whether monthly nucleic acid testing (NAT) for BKV replication in blood and immediate reduction of immunosuppression (IS) could prevent BKVN. METHODS NAT was performed at monthly intervals for 6 months and then at 12 months in 119 de novo renal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

BK Virus and Nephropathy in Kidney Transplant Recipients

International journal of organ transplantation medicine • 2016
View 1 Excerpt

Similar Papers

Loading similar papers…